Proteomic analysis may predict preterm labor.(Obstetrics)

Biomarkers of intra-amniotic infection and inflammation can be rapidly detected in amniotic fluid using proteomic analysis. And the identification of a distinctive biomarker profile can predict imminent preterm delivery with 100% accuracy, opening the door to future treatments, results of a recent study suggest.

"We are probably at a turning point in the history of preterm labor diagnosis," lead author Irina Buhimschi, M.D., of Yale University, New Haven, and her associates wrote (BJOG 2005;112:173-81). She conducted the research with Catalin S. Buhimschi, M.D., also of Yale, and Rob Christner of Ciphergen Biosystems, Fremont, Calif.

"We think this proteomic analysis will be the diagnostic platform of the future from which many diseases will be diagnosed," Dr. Irina Buhimschi commented in an interview.

The discovery could help identify preterm labor patients who might benefit from intervention "before the battle is completely lost," she explained.

Although amniotic fluid cultures can detect infection, they have limited clinical utility because results are not quickly available. "By the time you have the result, the patient has already delivered, and the baby is in neonatal intensive care--so the only benefit of the test is to confirm the decision of the physician. In the case of [proteomic analysis], the result can be available within 50 minutes or less and has the potential of being useful for clinical decision making," she said.

Using proteomic analysis, the team analyzed frozen amniotic fluid samples from 77 women with symptoms of preterm labor or preterm, premature rupture of membranes, and a known outcome (stage 1). The findings were then applied to samples from 24 symptomatic patients whose outcomes were not known to the investigators (stage 2).

The analysis identified a distinctive profile of four proteins present in patients who went on to preterm delivery but absent in ...